Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Fierce Pharma
Senate revives Orphan Cures Act in Trump's tax bill
The Senate's updated "big, beautiful bill" would allow drugs with multiple rare disease indications to be exempt from Medicare price negotiations.
Angus Liu
Jun 30, 2025 10:09am
Lower drug prices won't hurt biotech innovation, 2 studies show
Jul 31, 2024 2:30pm
US price negotiations could hit R&D harder than expected: study
Sep 6, 2023 10:20am
'On our minds': Novartis, GSK mull IRA impact on R&D strategies
Jul 26, 2023 11:06am
Biotechs lobby for their identity as drug pricing reforms set in
Jun 28, 2023 7:00am
VC firms, biotechs push back on drug pricing reforms
Jul 25, 2022 11:07am